Related Experiment Video
Updated: May 12, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine and obesity, is there a link?
1Consultation céphalées et douleur, centre hospitalier de la région Annecienne, 1, avenue de l'Hôpital, Metz Tessy, BP 90074, 74374 Pringy, France. pgiraud@ch-annecy.fr
Revue Neurologique
|April 23, 2013
Summary
Obesity is linked to increased migraine prevalence and can worsen headache conditions. Weight loss may improve migraine symptoms in obese individuals, suggesting shared underlying mechanisms.
Area of Science:
- Neurology and Public Health
- Epidemiology of Chronic Diseases
Background:
- Obesity and migraine are prevalent global health issues.
- Epidemiological studies indicate a significant association between obesity and increased migraine prevalence.
- Obesity may influence migraine characteristics and progression to chronic forms.
Purpose of the Study:
- To review existing epidemiological data on the relationship between obesity and migraine.
- To explore current hypotheses regarding common etiological factors and physiological mechanisms linking obesity and migraine.
- To highlight the impact of weight loss on migraine in obese populations.
Main Methods:
- Systematic review of large-scale epidemiological studies.
- Analysis of current scientific literature on shared physiological pathways.
- Discussion of proposed etiological hypotheses.
Main Results:
- Established epidemiological link showing higher migraine prevalence in obese individuals.
- Evidence suggesting weight loss can lead to migraine improvement in obese patients.
- Obesity's potential role in the progression of episodic migraine to chronic migraine.
Conclusions:
- A strong epidemiological association exists between obesity and migraine.
- Further research is needed to elucidate shared physiological mechanisms and common etiological factors.
- Weight management may be a relevant strategy for improving migraine outcomes in obese individuals.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
01:53Cause and Effect
While variables are sometimes correlated because one does cause the other, it could also be that some other factor, a confounding variable, is actually causing the systematic movement in our variables of interest. For instance, as sales in ice cream increase, so does the overall rate of crime. Is it possible that indulging in your favorite flavor of ice cream could send you on a crime spree? Or, after committing crime do you think you might decide to treat yourself to a cone?